Nvest Financial’s DexCom DXCM Stock Holding History

Nvest Financial’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,576	Closed	-$225K	–	125
2025 Q2	$225K	Buy	+2,576	New	+$202K	0.12%	102
2025 Q1	–	Sell	-2,576	Closed	-$200K	–	101
2024 Q4	$200K	Buy	+2,576	New	+$191K	0.1%	110
2024 Q3	–	Sell	-2,576	Closed	-$292K	–	92
2024 Q2	$292K	Hold	2,576	–	–	0.18%	75
2024 Q1	$357K	Hold	2,576	–	–	0.24%	63
2023 Q4	$320K	Hold	2,576	–	–	0.25%	59
2023 Q3	$240K	Hold	2,576	–	–	0.22%	56
2023 Q2	$331K	Buy	+2,576	New	+$312K	0.29%	51

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nvest Financial's DXCM Position: Q3 2025 in Review

Nvest Financial sold out of DexCom (DXCM) in Q3 2025, closing a stake of 2,576 shares — an estimated $225K sold.

Nvest Financial first reported a position in DXCM in Q2 2023 and held it in 7 quarters. The position peaked at $357K in Q1 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

Nvest Financial reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
Nvest Financial sold 2,576 DexCom shares in Q3 2025, an estimated $225K.
Nvest Financial first reported a position in DexCom in Q2 2023 and held it in 7 quarters.
Nvest Financial's DexCom position peaked at $357K in Q1 2024.
911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Nvest Financial's 13F filing for Q3 2025, filed 13 Nov 2025.